Terry Rudd has covered clinical news and health policy as a reporter and editor since 1994.
Video
VIDEO: New topical acne therapies will target sebum
Three topical acne drugs that target the production of sebum are now in clinical trials.
Video
VIDEO: IL-17 antagonists continue reshaping psoriasis therapy in 2016
IL-17 antagonists should continue to reshape psoriasis therapy in 2016, Dr. Craig Leonardi predicted.
Video
VIDEO: U.S. hepatitis C treatment capacity falls short of need
Despite new hepatitis C treatment options, the health care system’s capacity to treat patients still falls far short of what’s needed.
Video
VIDEO: 12-week HCV retreatment effective if short course fails
Patients who fail short-course treatment for hepatitis C and show high levels of resistance to an antiviral drug may still respond to standard 12-...
Video
VIDEO: Longer HCV therapy worked even after short-term failures
Patients with HCV who fail short-course antiviral treatment may still be able to achieve a cure using longer-duration therapies plus ribavirin.
Video
VIDEO: Antigen test could simplify HCV screening
A new test focused on hepatitis C antigen detection might simplify the HCV screening process and reduce its costs.
Video
VIDEO: Inappropriate hepatitis A, B tests may be widespread in hospitals
Hospital physicians may be ordering too many inappropriate lab tests in cases of suspected acute hepatitis A and hepatitis B.
Video
VIDEO: Survival benefits, relapse risks in liver transplant for alcoholic hepatitis
Early liver transplantation in 40 patients with severe alcoholic hepatitis achieved a 100% survival rate at 1 year, with a 22% alcohol relapse...
Video
VIDEO: Eating before liver stiffness test may skew results
Expanding the time between a liver fibrosis patient’s last meal and liver stiffness test may improve the accuracy of the test.
Video
VIDEO: Expert outlines new thinking on irritable bowel syndrome
New medications and more patient-focused strategies are changing the treatment of irritable bowel syndrome.
Video
VIDEO: Serum amyloid A could be IBD biomarker
Serum amyloid A levels may offer an effective biomarker to gauge disease activity in inflammatory bowel disease.
Video
VIDEO: Gut microbiota may predict C. diff treatment response
Gut microbiota may be an effective predictor of Clostridium difficile treatment response.